Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. - Wikidata - wikimedia - TriplyDB

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

http://www.wikidata.org/entity/Q45952178

about

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants Adaptive immunity in the liver Primary biliary cirrhosis: From bench to bedside Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases Mechanisms of immune-mediated liver injury.Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction.The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity.Role of cholangiocytes in primary biliary cirrhosis.Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature.The autoimmunity of primary biliary cirrhosis and the clonal selection theory.Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Immune-mediated bile duct injury: The case of primary biliary cirrhosis.Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment.Tolerance Induction in Liver Transient regulatory T-cells: a state attained by all activated human T-cells.Epstein-barr virus as a trigger of autoimmune liver diseases.Sex differences associated with primary biliary cirrhosis.Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.Advances in pharmacotherapy for primary biliary cirrhosis.Role of autoimmunity in primary biliary cirrhosis.CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis Cellular and molecular mechanisms of liver tolerance.Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.Animal models of primary biliary cirrhosis Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.The unfinished business of primary biliary cirrhosis Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border.T-regulatory lymphocytes and chronic viral hepatitis.Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice

P2860

Q24617796-FE5DC4D9-7CA8-4447-BEFE-1BE7325CD4E1 Q26753195-156C3177-8887-4888-AF26-44CA265DA70D Q26799419-679DD577-8083-4816-9B39-0463B1BDE841 Q26827787-67FA2573-5BCA-4819-A434-4F4A40D2DA6A Q26992087-D076476C-9B2C-4426-AC9F-B5EC7091DC05 Q28069832-EE6C05ED-EC35-4542-9CFF-B41141FBBDC1 Q30437183-64C14D02-3B35-4DB1-9053-4B0796707A70 Q33650813-27E66B2B-F8AB-479D-BB2C-B9428547158D Q33856306-A9748265-DC52-42C9-9CE5-239D3A886663 Q33903561-309EA1C2-7DEF-4639-9C2E-D2CABEF37B7F Q34070579-26F93073-E3CD-4074-8394-3FC50F28F1CB Q34071745-F3298286-C98B-4E3E-951F-57AD87DF4D19 Q34276575-52164881-F320-4F31-8AA5-1FE439C84E7A Q34346124-0ABE4773-1468-4266-8CE2-2EBAC19042AE Q34472336-2D5C2296-6435-480D-B166-462D7BFB6D71 Q34482519-0BEF722C-0CD3-484E-A1E5-B5D14AB43C07 Q34992341-5DE686CE-F743-4355-897C-1B7DCC9C8027 Q34992359-757A0166-63E4-4CC4-8C04-A951C7FD30BB Q35148923-1B4D9897-F971-44F9-8B7F-2C54F3493CA0 Q35309080-AC94D200-E0F7-4750-9139-14F08EA73AC1 Q35687041-9FA5753C-680D-44F0-BA2B-51D74A12D010 Q35727669-C6E934F2-F206-4901-9E00-DF7B921A75D1 Q35792962-1291C6D5-986F-44B4-9CA4-51979978B2AB Q36010920-C0C04459-7AF3-4A89-9B86-DC8C839EBDBA Q36014535-00B237DD-FAA4-40B8-9EB2-9FDE0150A9B9 Q36034835-873CC2ED-DEE1-4A4C-8024-FDA7F8AEBAAF Q36116022-582E22A6-91F5-4733-9076-0EE5790E843A Q36529131-4220CCC4-31C2-4693-B386-1CA57B6A9004 Q36557102-388BF517-72CD-4399-8152-233DF814E6B8 Q36593734-68BCF65A-D655-443C-A6D3-9D9D0ABB0D11 Q36708065-6F6C9AA8-828C-40FA-8E63-CA8DFBF8A3CB Q36779199-BB2725EA-9F0C-4408-968C-ED3EFCC89A54 Q36791956-DA9849B8-D261-4692-86E1-C121D875C81F Q36791960-A61372EF-7804-4EC7-BA9E-1BDFE36FEFF4 Q36890818-CDD39F0F-6AC2-4226-AABA-FB5B3C875EF8 Q36914332-B2AD9F68-B23D-4424-AEF8-0BE44FB3DD00 Q36943071-90C4C3A8-D9FC-44F3-BBBC-DC9EAB92E9EA Q36949181-BCD25EE0-2E38-4FFF-BD3B-9DC4ABD4358C Q36981671-77EAEB61-7826-4894-B12D-41DA4E8F886E Q37038475-C9BB97D9-7C3D-4A82-B1F3-C9E0071CB6D2

P2860

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

http://www.wikidata.org/entity/Q45952178

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@en

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@nl

type

label

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@en

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@nl

prefLabel

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@en

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@nl

P1433

Q45952178-E4A24F8B-978F-4AB8-9A03-253D8764C422

P1476

Q45952178-4DF0ABD0-70E1-4B83-86D2-FCF0C66AE76A

P2093

Q45952178-1FE58F3C-EE9B-4B64-9AC5-5552BB0F79CC

Q45952178-2B590FA5-76D9-4CD0-A3C5-A12C3BE2455A

Q45952178-3DD6B64A-AA6F-40E1-A1B6-3D0A5ABA77C4

Q45952178-5404EE27-5B4F-4807-B5C5-56FFB1E2938E

Q45952178-5B4BA0FD-754B-421A-B2C6-226393F0F637

Q45952178-62F8B2D2-2B81-4376-965D-8118348331BB

Q45952178-71D3660F-38DB-4685-8B7C-40B45384C0C1

Q45952178-8EAAD560-6913-4927-8E47-2B71D0F417E8

Q45952178-964888E9-C506-4294-951B-4029AD677F40

Q45952178-BC4A7CF1-B4AB-4C98-8322-F70ECC5D720B

P2860

Q45952178-34582C92-B2B3-404B-A001-6FBA0DD1609E

Q45952178-D009ABE1-ADBB-4476-AAD5-A53F2FE84E39

Q45952178-D1483D6B-B776-4534-BF54-07714B837DF3

Q45952178-F10B44CF-91A2-4D6D-9504-84A412474411

P304

Q45952178-0955E647-7226-4201-B93B-251B4583B3B8

P31

Q45952178-FE928850-5E3C-45B0-96FA-58EC86DE3678

P356

Q45952178-7EAF932D-99E7-4A2C-90E2-25C7FAC54F23

P407

Q45952178-F37C67FB-9D51-4E3E-BD56-5BB58397C494

P433

Q45952178-D8E37065-E641-4A1F-8068-06040243AF68

P478

Q45952178-510370FA-7C5E-4809-9FFB-C20F2B3172A3

P50

Q45952178-2AE54EF0-E347-442F-8B1D-B5F8DBF4F801

Q45952178-3219CB99-B5D8-42E2-BB80-F8DD9436E329

Q45952178-3BD61A0D-EC91-4733-80BB-665EDD593DCE

Q45952178-AC3D99B1-29BB-45F7-AF18-219375632568

P577

Q45952178-3E418478-FE79-45C1-8087-7DE8426EBC67

P5875

Q45952178-E270D62A-97DF-41B2-8C1E-F2223DED1E24

P698

Q45952178-3D2D59C0-5582-4ACB-A2DA-81B046723B08

P921

Q45952178-DF48948D-7C4E-477F-9F0A-4D555BD1E8C6

P356

P1433

P1476

Liver-targeted and peripheral ...... in primary biliary cirrhosis.

@en

P2093

Atsushi Tanaka

http://www.w3.org/2001/XMLSchema#string

Christopher L Bowlus

http://www.w3.org/2001/XMLSchema#string

Chunmei Cheng

http://www.w3.org/2001/XMLSchema#string

Guo-Xiang Yang

http://www.w3.org/2001/XMLSchema#string

Koichi Tsuneyama

http://www.w3.org/2001/XMLSchema#string

Ruth Y Lan

http://www.w3.org/2001/XMLSchema#string

Shigeru Saito

http://www.w3.org/2001/XMLSchema#string

Shinji Shimoda

http://www.w3.org/2001/XMLSchema#string

Takafumi Nakamura

http://www.w3.org/2001/XMLSchema#string

Ya-Hui Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple immuno-regulatory defects in type-1 diabetes

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism.

CD4+ Tregs and immune control.

Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment.

P304

729-737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21123

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

M. Eric Gershwin

Aftab A. Ansari

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7220836

http://www.w3.org/2001/XMLSchema#string

P698

16557534

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis